Spermatogonium

Last updated
Spermatogonium [1]
Germinal epithelium testicle.svg
Germinal epithelium of the testicle. 1 basal lamina, 2 spermatogonia, 3 spermatocyte 1st order, 4 spermatocyte 2nd order, 5 spermatid, 6 mature spermatid, 7 Sertoli cell, 8 tight junction (blood testis barrier)
Testicle-histology-boar.jpg
Histological section through testicular parenchyma of a boar. 1 Lumen of Tubulus seminiferus contortus, 2 spermatids, 3 spermatocytes, 4 spermatogonia, 5 Sertoli cell, 6 myofibroblasts, 7 Leydig cells, 8 capillaries
Identifiers
MeSH D013093
FMA 72291
Anatomical terminology

A spermatogonium (plural: spermatogonia) is an undifferentiated male germ cell. Spermatogonia undergo spermatogenesis to form mature spermatozoa in the seminiferous tubules of the testicles.

Contents

There are three subtypes of spermatogonia in humans:

Type A (dark) cells, with dark nuclei. These cells are reserve spermatogonial stem cells which do not usually undergo active mitosis. Type A (pale) cells, with pale nuclei. These are the spermatogonial stem cells that undergo active mitosis. These cells divide to produce Type B cells. Type B cells, which undergo growth and become primary spermatocytes.

Types of spermatogonia

Spermatogonia are often classified into different types depending on their stage in the differentiation process. In humans and most mammals, spermatogonia are divided into two types, A and B, but this can differ for other organisms. [2]

There are three subtypes of spermatogonia in humans:

Spermatogenesis

Spermatogenesis is the process in which sperm cells are produced and formed into mature spermatozoa from spermatogonia. Males mature spermatozoa (sperm) are produced to later join with a female oocyte (egg) to create offspring. Throughout the process of spermatogenesis, there are many different parts of the male anatomy, accessory organs, and hormones. However, spermatogenesis can be broken down in the following steps, which are initiated at the start of puberty:

Male hormones

Spermatogenesis is a very regulated process controlled by endocrine stimuli. These stimuli include the follicle-stimulating hormone (FSH) and the luteinizing hormone (LH), which stimulate testosterone. These hormones produce regulatory signals that control the maintenance and nutrients needed for the developing germ cells. The following explains what each hormone contributes to the regulation of spermatogenesis.

Sperm structure

The overall structure of spermatozoa is very specialized as the cell has fully differentiated and matured. As spermatozoa, the cell no longer undergoes division. It consists of a head, midpiece, and flagella tail for motility.  

Infertility

Infertility is the inability of a couple to conceive an offspring after a year of unprotected intercourse. Spermatogonia plays a vital role in male fertility, as they are the initial germ cells for sperm production. A disruption of spermatogonia’s function, structure, or development can lead to infertility. There are several factors that can affect spermatogenesis and the health of spermatogonia, including genetic disorders, hormonal imbalances, environmental factors, and many more. [7]  

Diseases That Cause Infertility

There are many diseases and causes of infertility experienced in males.

Cystic Fibrosis and Klinefelter's Syndrome are just two examples of ways diseases and genetic mutations can lead to infertility in men.

Anticancer drugs

Anticancer drugs such as doxorubicin and vincristine can adversely affect male fertility by damaging the DNA of proliferative spermatogonial stem cells. Experimental exposure of rat undifferentiated spermatogonia to doxorubicin and vincristine indicated that these cells are able to respond to DNA damage by increasing their expression of DNA repair genes, and that this response likely partially prevents DNA break accumulation. [11] In addition to a DNA repair response, exposure of spermatogonia to doxorubicin can also induce programmed cell death (apoptosis). [12]

Additional images

See also

Related Research Articles

<span class="mw-page-title-main">Gametogenesis</span> Biological process

Gametogenesis is a biological process by which diploid or haploid precursor cells undergo cell division and differentiation to form mature haploid gametes. Depending on the biological life cycle of the organism, gametogenesis occurs by meiotic division of diploid gametocytes into various gametes, or by mitosis. For example, plants produce gametes through mitosis in gametophytes. The gametophytes grow from haploid spores after sporic meiosis. The existence of a multicellular, haploid phase in the life cycle between meiosis and gametogenesis is also referred to as alternation of generations.

<span class="mw-page-title-main">Follicle-stimulating hormone</span> Gonadotropin that regulates the development of reproductive processes

Follicle-stimulating hormone (FSH) is a gonadotropin, a glycoprotein polypeptide hormone. FSH is synthesized and secreted by the gonadotropic cells of the anterior pituitary gland and regulates the development, growth, pubertal maturation, and reproductive processes of the body. FSH and luteinizing hormone (LH) work together in the reproductive system.

<span class="mw-page-title-main">Germ cell</span> Gamete-producing cell

A germ cell is any cell that gives rise to the gametes of an organism that reproduces sexually. In many animals, the germ cells originate in the primitive streak and migrate via the gut of an embryo to the developing gonads. There, they undergo meiosis, followed by cellular differentiation into mature gametes, either eggs or sperm. Unlike animals, plants do not have germ cells designated in early development. Instead, germ cells can arise from somatic cells in the adult, such as the floral meristem of flowering plants.

<span class="mw-page-title-main">Spermatogenesis</span> Production of sperm

Spermatogenesis is the process by which haploid spermatozoa develop from germ cells in the seminiferous tubules of the testicle. This process starts with the mitotic division of the stem cells located close to the basement membrane of the tubules. These cells are called spermatogonial stem cells. The mitotic division of these produces two types of cells. Type A cells replenish the stem cells, and type B cells differentiate into primary spermatocytes. The primary spermatocyte divides meiotically into two secondary spermatocytes; each secondary spermatocyte divides into two equal haploid spermatids by Meiosis II. The spermatids are transformed into spermatozoa (sperm) by the process of spermiogenesis. These develop into mature spermatozoa, also known as sperm cells. Thus, the primary spermatocyte gives rise to two cells, the secondary spermatocytes, and the two secondary spermatocytes by their subdivision produce four spermatozoa and four haploid cells.

<span class="mw-page-title-main">Sertoli cell</span> Cells found in human testes which help produce sperm

Sertoli cells are a type of sustentacular "nurse" cell found in human testes which contribute to the process of spermatogenesis as a structural component of the seminiferous tubules. They are activated by follicle-stimulating hormone (FSH) secreted by the adenohypophysis and express FSH receptor on their membranes.

<span class="mw-page-title-main">Spermatocyte</span> Sperm precursor cell that undergoes meiosis

Spermatocytes are a type of male gametocyte in animals. They derive from immature germ cells called spermatogonia. They are found in the testis, in a structure known as the seminiferous tubules. There are two types of spermatocytes, primary and secondary spermatocytes. Primary and secondary spermatocytes are formed through the process of spermatocytogenesis.

<span class="mw-page-title-main">Human reproductive system</span> Organs involved in reproduction

The human reproductive system includes the male reproductive system, which functions to produce and deposit sperm, and the female reproductive system, which functions to produce egg cells and to protect and nourish the fetus until birth. Humans have a high level of sexual differentiation. In addition to differences in nearly every reproductive organ, there are numerous differences in typical secondary sex characteristics.

<span class="mw-page-title-main">Azoospermia</span> Medical condition of a man whose semen contains no sperm

Azoospermia is the medical condition of a man whose semen contains no sperm. It is associated with male infertility, but many forms are amenable to medical treatment. In humans, azoospermia affects about 1% of the male population and may be seen in up to 20% of male infertility situations in Canada.

<span class="mw-page-title-main">Spermiogenesis</span> Final stage of spermatogenesis, involving spermatid maturation

Spermiogenesis is the final stage of spermatogenesis, during which the spermatids develop into mature spermatozoa. At the beginning of the stage, the spermatid is a more or less circular cell containing a nucleus, Golgi apparatus, centriole and mitochondria; by the end of the process, it has radically transformed into an elongated spermatozoon, complete with a head, midpiece, and tail.

Male infertility refers to a sexually mature male's inability to impregnate a fertile female. In humans, it accounts for 40–50% of infertility. It affects approximately 7% of all men. Male infertility is commonly due to deficiencies in the semen, and semen quality is used as a surrogate measure of male fecundity. More recently, advance sperm analyses that examine intracellular sperm components are being developed.

Spermatogenesis arrest is known as the interruption of germinal cells of specific cellular type, which elicits an altered spermatozoa formation. Spermatogenic arrest is usually due to genetic factors resulting in irreversible azoospermia. However some cases may be consecutive to hormonal, thermic, or toxic factors and may be reversible either spontaneously or after a specific treatment. Spermatogenic arrest results in either oligospermia or azoospermia in men. It is quite a difficult condition to proactively diagnose as it tends to affect those who have normal testicular volumes; a diagnosis can be made however through a testicular biopsy.

<span class="mw-page-title-main">Adjudin</span> Chemical compound

Adjudin (AF-2364) is a drug which is under development as a potential non-hormonal male contraceptive drug, which acts by blocking the production of sperm in the testes, but without affecting testosterone production. It is an analogue of the chemotherapy drug lonidamine, an indazole-carboxylic acid, and further studies continue to be conducted into this family of drugs as possible contraceptives.

<span class="mw-page-title-main">Sertoli cell-only syndrome</span> Medical condition

Sertoli cell-only syndrome (SCOS), also known as germ cell aplasia, is defined by azoospermia where the testicular seminiferous tubules are lined solely with sertoli cells. Sertoli cells contribute to the formation of the blood-testis barrier and aid in sperm generation. These cells respond to follicle-stimulating hormone, which is secreted by the hypothalamus and aids in spermatogenesis.

Gonocytes are the precursors of spermatogonia that differentiate in the testis from primordial germ cells around week 7 of embryonic development and exist up until the postnatal period, when they become spermatogonia. Despite some uses of the term to refer to the precursors of oogonia, it was generally restricted to male germ cells. Germ cells operate as vehicles of inheritance by transferring genetic and epigenetic information from one generation to the next. Male fertility is centered around continual spermatogonia which is dependent upon a high stem cell population. Thus, the function and quality of a differentiated sperm cell is dependent upon the capacity of its originating spermatogonial stem cell (SSC).

<span class="mw-page-title-main">Leydig cell hypoplasia</span> Medical condition

Leydig cell hypoplasia (LCH), also known as Leydig cell agenesis, is a rare autosomal recessive genetic and endocrine syndrome affecting an estimated 1 in 1,000,000 individuals with XY chromosomes. It is characterized by an inability of the body to respond to luteinizing hormone (LH), a gonadotropin which is normally responsible for signaling Leydig cells of the testicles to produce testosterone and other androgen sex hormones. The condition manifests itself as pseudohermaphroditism, hypergonadotropic hypogonadism, reduced or absent puberty, and infertility.

Follicle-stimulating hormone (FSH) insensitivity, or ovarian insensitivity to FSH in females, also referable to as ovarian follicle hypoplasia or granulosa cell hypoplasia in females, is a rare autosomal recessive genetic and endocrine syndrome affecting both females and males, with the former presenting with much greater severity of symptomatology. It is characterized by a resistance or complete insensitivity to the effects of follicle-stimulating hormone (FSH), a gonadotropin which is normally responsible for the stimulation of estrogen production by the ovaries in females and maintenance of fertility in both sexes. The condition manifests itself as hypergonadotropic hypogonadism, reduced or absent puberty, amenorrhea, and infertility in females, whereas males present merely with varying degrees of infertility and associated symptoms.

<span class="mw-page-title-main">Spermatogonial stem cell</span> Spermatogonium that does not differentiate into a spermatocyte

A spermatogonial stem cell (SSC), also known as a type A spermatogonium, is a spermatogonium that does not differentiate into a spermatocyte, a precursor of sperm cells. Instead, they continue dividing into other spermatogonia or remain dormant to maintain a reserve of spermatogonia. Type B spermatogonia, on the other hand, differentiate into spermatocytes, which in turn undergo meiosis to eventually form mature sperm cells.

In vitro spermatogenesis is the process of creating male gametes (spermatozoa) outside of the body in a culture system. The process could be useful for fertility preservation, infertility treatment and may further develop the understanding of spermatogenesis at the cellular and molecular level. 

<span class="mw-page-title-main">Side effects of radiotherapy on fertility</span>

The side effects of radiotherapy on fertility are a growing concern to patients undergoing radiotherapy as cancer treatments. Radiotherapy is essential for certain cancer treatments and often is the first point of call for patients. Radiation can be divided into two categories: ionising radiation (IR) and non-ionising radiation (NIR). IR is more dangerous than NIR and a source of this radiation is X-rays used in medical procedures, for example in radiotherapy.

The germ cell nest forms in the ovaries during their development. The nest consists of multiple interconnected oogonia formed by incomplete cell division. The interconnected oogonia are surrounded by somatic cells called granulosa cells. Later on in development, the germ cell nests break down through invasion of granulosa cells. The result is individual oogonia surrounded by a single layer of granulosa cells. There is also a comparative germ cell nest structure in the developing spermatogonia, with interconnected intracellular cytoplasmic bridges.

References

  1. Mahla, R.S. (2012). "Spermatogonial Stem Cells (SSCs) in Buffalo (Bubalus bubalis) Testis". PLOS ONE. 7 (4): e36020. Bibcode:2012PLoSO...736020M. doi: 10.1371/journal.pone.0036020 . PMC   3334991 . PMID   22536454.
  2. Waheeb, R.; Hofmann, M.-C. (August 2011). "Human spermatogonial stem cells: a possible origin for spermatocytic seminoma". International Journal of Andrology. 34 (4 Pt 2): e296–305, discussion e305. doi:10.1111/j.1365-2605.2011.01199.x. ISSN   1365-2605. PMC   3146023 . PMID   21790653.
  3. 1 2 3 4 "Spermatogenesis". Default. Retrieved 2024-12-04.
  4. 1 2 3 4 5 6 7 8 Sharma, Rakesh; Agarwal, Ashok (2011), Zini, Armand; Agarwal, Ashok (eds.), "Spermatogenesis: An Overview", Sperm Chromatin: Biological and Clinical Applications in Male Infertility and Assisted Reproduction, New York, NY: Springer, pp. 19–44, doi:10.1007/978-1-4419-6857-9_2, ISBN   978-1-4419-6857-9 , retrieved 2024-12-04
  5. Oduwole, Olayiwola O.; Peltoketo, Hellevi; Huhtaniemi, Ilpo T. (2018-12-14). "Role of Follicle-Stimulating Hormone in Spermatogenesis". Frontiers in Endocrinology. 9: 763. doi: 10.3389/fendo.2018.00763 . ISSN   1664-2392. PMC   6302021 . PMID   30619093.
  6. Suede, Samah H.; Malik, Ahmad; Sapra, Amit (2024), "Histology, Spermatogenesis", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   31985935 , retrieved 2024-12-04
  7. Leslie, Stephen W.; Soon-Sutton, Taylor L.; Khan, Moien AB (2024), "Male Infertility", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   32965929 , retrieved 2024-12-04
  8. "Cystic Fibrosis — What Is Cystic Fibrosis?". NHLBI, NIH. 2024-11-15. Retrieved 2024-12-04.
  9. Naz Khan, Farah; Mason, Kelly; H Roe, Andrea; Tangpricha, Vin (2022). "CF and male health: Sexual and reproductive health, hypogonadism, and fertility". Journal of Clinical & Translational Endocrinology. 27: 100288. doi:10.1016/j.jcte.2021.100288. PMC   8695349 . PMID   34987977.
  10. Hawksworth DJ, Szafran AA, Jordan PW, Dobs AS, Herati AS (2018). "Infertility in Patients With Klinefelter Syndrome: Optimal Timing for Sperm and Testicular Tissue Cryopreservation". Rev Urol. 20 (2): 56–62. doi:10.3909/riu0790 (inactive 17 December 2024). PMC   6168324 . PMID   30288141.{{cite journal}}: CS1 maint: DOI inactive as of December 2024 (link)
  11. Beaud H, van Pelt A, Delbes G (2017). "Doxorubicin and vincristine affect undifferentiated rat spermatogonia". Reproduction. 153 (6): 725–735. doi: 10.1530/REP-17-0005 . PMID   28258155.
  12. Habas K, Anderson D, Brinkworth MH (2017). "Germ cell responses to doxorubicin exposure in vitro" (PDF). Toxicol. Lett. 265: 70–76. doi:10.1016/j.toxlet.2016.11.016. hdl: 10454/10685 . PMID   27890809.